Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Procter & Gamble Health Ltd. (PGHL) Stock Price & Analysis

4 Followers

PGHL Stock Chart & Stats

₹5,806.10₹8.20(0.14%)
At close: 3:30 PM GMT+5:30
₹5K₹5.25K₹5.5K₹5.75KAug 17Aug 31Sep 15Sep 28Oct 12Oct 26Nov 9
Day’s Range
INR 5,713.85 - INR 5,858.00
52-Week Range
INR 4,699.70 - INR 6,955.00
Previous Close
INR 5,797.90
Volume
N/A
Average Volume (3M)
420
Market Cap
INR 96.24B
Enterprise Value
INR 77.89B
Total Cash (Recent Filing)
INR 1.85B
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
25.4
Beta
0.36
Next Earnings
May 06, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Aug 27, 2026
Dividend Yield
3.64%

Bulls Say, Bears Say

Bulls Say

Profitability And Brand Strength

High, resilient margins and rising earnings indicate that PGHL’s established healthcare brands support durable customer demand and pricing power. This strengthens earnings resilience and provides a foundation for continued investment in distribution, product support, and consumer health growth.

Conservative Balance Sheet

Minimal leverage materially reduces financial risk and interest-related pressure, giving PGHL flexibility to withstand operating volatility and fund its business from a stable capital base. Strong returns generated without heavy borrowing also support the quality of its underlying model.

Improving Cash Generation

The sharp latest-year free-cash-flow rebound demonstrates improving cash conversion and strengthens PGHL’s ability to fund operations, dividends, and reinvestment internally. If sustained, stronger cash generation should reinforce financial resilience and reduce reliance on external capital.

Bears Say

Uneven Revenue Trajectory

Recent growth is encouraging, but the prior revenue decline shows that demand has not advanced consistently across periods. An uneven top-line trajectory can make capacity planning and earnings forecasting less predictable, requiring continued execution to sustain momentum in consumer healthcare.

Volatile Cash Conversion

Although free cash flow improved sharply in 2026, earlier periods of weak cash conversion and declining free cash flow indicate that accounting earnings have not always translated consistently into available cash. This may constrain the reliability of funding for dividends and growth initiatives.

Reduced Asset And Equity Base

A smaller equity and asset base versus 2023 is a structural watch point because it may reduce the resources supporting future expansion and absorb less operating variability. Low leverage limits financial risk, but the contraction still warrants monitoring for its effect on business scale.

Procter & Gamble Health Ltd. News

PGHL FAQ

What was Procter & Gamble Health Ltd.’s price range in the past 12 months?
Procter & Gamble Health Ltd. lowest stock price was ₹4699.70 and its highest was ₹6955.00 in the past 12 months.
What is Procter & Gamble Health Ltd.’s market cap?
Procter & Gamble Health Ltd.’s market cap is ₹96.24B.
When is Procter & Gamble Health Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Procter & Gamble Health Ltd.’s earnings last quarter?
Procter & Gamble Health Ltd. released its earnings results on Aug 06, 2026. The company reported ₹57.9 earnings per share for the quarter.
Is Procter & Gamble Health Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Procter & Gamble Health Ltd. pay dividends?
Procter & Gamble Health Ltd. pays a semiannual dividend of ₹45 which represents an annual dividend yield of 3.64%. See more information on Procter & Gamble Health Ltd. dividends here
What is Procter & Gamble Health Ltd.’s EPS estimate?
Procter & Gamble Health Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Procter & Gamble Health Ltd. have?
Procter & Gamble Health Ltd. has 16,599,382 shares outstanding.
What happened to Procter & Gamble Health Ltd.’s price movement after its last earnings report?
Procter & Gamble Health Ltd. reported an EPS of ₹57.9 in its last earnings report. Following the earnings report the stock price went down -5.74%.
Which hedge fund is a major shareholder of Procter & Gamble Health Ltd.?
Currently, no hedge funds are holding shares in IN:PGHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology